Business Wire

The Estée Lauder Companies Announces Brand Leadership Appointments

3.9.2026 16:37:00 CEST | Business Wire | Press release

Share

The Estée Lauder Companies Inc. (NYSE: EL) today announced several brand leadership appointments following the upcoming retirement of Sandra Main, Global Brand President, La Mer and Skin Care Brands.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260902005552/en/

Justin Boxford, Global President, Luxury Beauty Brands, Erica Kwok, Senior Vice President and General Manager of Estée Lauder, and Magalie Parksuwan, Senior Vice President and General Manager, La Mer

Justin Boxford will assume the newly established role of Global President, Luxury Beauty Brands, expanding his portfolio to include La Mer alongside Estée Lauder, AERIN, Darphin Paris and Lab Series.

Justin brings extensive experience with La Mer, having led the brand from 2017 to 2022 before assuming leadership of Estée Lauder. During his tenure, he expanded and diversified La Mer’s product portfolio, strengthened its luxury architecture and advanced the brand’s presence across digital and omnichannel platforms. Today, La Mer is the number one luxury skin care brand in the world. In his expanded role, Justin will lead the La Mer team as it builds on the strong foundation established by Sandra and guides the brand into its next chapter.

Erica Kwok will be appointed Senior Vice President and General Manager of Estée Lauder, the Company’s flagship brand, whose portfolio spans luxury skin care, makeup and fragrance and reaches consumers in more than 150 countries.

With more than 20 years of beauty industry experience, including 15 years with the Estée Lauder brand, Erica brings a strong combination of strategic vision, operational excellence and global market expertise to the role. She joined the Global Brand from Asia/Pacific in 2021 and, over the past several years, has led Marketing, Product Development and Global Growth in an expanded role, helping to create a more integrated approach across the brand’s key growth drivers. She also played a pivotal role in recent launches, including Double Wear and Glimmer. Erica will partner closely with Justin as she leads Estée Lauder into its next chapter.

Magalie Parksuwan will continue as Senior Vice President and General Manager, La Mer, reporting directly to Justin. In addition, she will oversee Darphin Paris and Lab Series, supporting Pierre-Olivier Garcin, Senior Vice President and General Manager, Darphin Paris and Lab Series.

Magalie brings extensive experience building global luxury brands across skin care, fragrance and makeup, as well as a deep understanding of consumers and distribution channels across key markets. Her strategic acumen, creativity and passion for luxury will position her to lead La Mer into its next phase of growth while further strengthening Darphin Paris and Lab Series globally.

“These appointments reflect the exceptional strength of our leadership bench and our deep commitment to developing world-class talent from within,” said Jane Hertzmark Hudis, Executive Vice President and Chief Brand Officer, The Estée Lauder Companies. “Justin, Erica and Magalie each bring distinctive expertise, proven leadership and a deep passion for our brands. Together, they will build on the strong foundations of these businesses, drive continued growth and innovation, and position our brands for long-term success.”

ELC-C, ELC-B

About The Estée Lauder Companies
The Estée Lauder Companies Inc. is one of the world’s leading manufacturers, marketers and sellers of quality skin care, makeup, fragrance and hair care products, and is a steward of luxury and prestige brands globally. The Company’s products are sold in approximately 150 countries and territories under brand names including: Estée Lauder, Aramis, Clinique, Lab Series, Origins, M·A·C, La Mer, Bobbi Brown Cosmetics, Aveda, Jo Malone London, Bumble and bumble, Darphin Paris, TOM FORD, Smashbox, AERIN Beauty, Le Labo, Editions de Parfums Frédéric Malle, GLAMGLOW, KILIAN PARIS, Too Faced, Dr.Jart+, the DECIEM family of brands, including The Ordinary, NIOD, Avestan and Loopha, and Balmain Beauty.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260902005552/en/

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 10:15:00 CEST | Press release

Potential first-in-class GPC3 x 4-1BB bispecific achieves a 36% confirmed response rate at Phase 3 dose and favorable safety profile in heavily pretreated liver cancerBrain-penetrant PRMT5 inhibitor shows promising antitumor and CNS activity in the largest publicly shared MTAP-deficient datasetFirst clinical data of CEA-targeting ADC demonstrates encouraging and sustained responses in CEAhigh NSCLC BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to dise

Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press release

- Vertex is on track for the U.S. FDA Prescription Drug User Fee Act (PDUFA) date of November 30 for potential accelerated approval of povetacicept –- Data published in NEJM and presented at ASN highlight povetacicept’s unique trifecta of efficacy, favorable safety, and the simplicity of dosing at-home every 4 weeks with a low-volume autoinjector –- Data presented at ASN include a qualitative study examining patient perspectives on current and emerging IgAN therapies, showing that 96% of participants preferred an autoinjector over a prefilled syringe, and 80% of participants preferred dosing every 4 weeks versus weekly dosing - - New clinical studies of povetacicept underway including a study evaluating patient experience on povetacicept administered via autoinjector - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Soc

BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press release

New data from HERIZON-GEA-01 Phase 3 trial show 36-month overall survival of nearly 40% with TEVIMBRA plus ZIIHERA and chemotherapy, and median OS reaching 27 monthsTEVIMBRA-containing arm was associated with a four-month longer median OS compared with ZIIHERA plus chemotherapy BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne,

Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:10:00 CEST | Press release

Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com

inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press release

Collaboration will establish the roadmap for bringing Pony.ai robotaxis to Kazakhstan on the inDrive ride-hailing platform, leveraging the NVIDIA Hyperion and the NVIDIA Halos safety system. inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a lea

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye